JP Morgan Chase
HALO icon

JP Morgan Chase’s Halozyme HALO Stock Holding History

JP Morgan Chase’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-35,000
Closed -$590K – 5824
2019
Q2 		$590K Buy
35,000
+5,000
+17% +$80.7K ﹤0.01% 4159
2019
Q1 		$483K Hold
30,000
– – ﹤0.01% 4223
2018
Q4 		$439K Buy
+30,000
New +$479K ﹤0.01% 4199
2018
Q1 		– Sell
-100,000
Closed -$2.03M – 5483
2017
Q4 		$2.03M Buy
+100,000
New +$1.84M ﹤0.01% 3316

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase's HALO Position: Q1 2026 in Review

JP Morgan Chase increased its Halozyme (HALO) stake by 46% in Q1 2026, buying an estimated $14M and bringing the position to 633,730 shares worth $39.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1538.

JP Morgan Chase first reported a position in HALO in Q2 2013 and has held it in 52 quarters since. The position peaked at $239M in Q2 2021. 635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • JP Morgan Chase held 633,730 shares of Halozyme worth $39.4M as of Q1 2026.
  • JP Morgan Chase bought 199,193 Halozyme shares in Q1 2026, an estimated $14M.
  • Halozyme made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #1538 holding.
  • JP Morgan Chase first reported a position in Halozyme in Q2 2013 and has held it in 52 quarters since.
  • JP Morgan Chase's Halozyme position peaked at $239M in Q2 2021.
  • 635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.